Chetan Puttagunta
CIK 1695859 · last filed 2026-10-19
Chetan Puttagunta is a corporate insider who has filed 16 SEC Form 4 insider transactions across 4 companies since 2018. The most recent filing, for ESTC, was dated Oct 19, 2026. Across all open-market trades the lifetime net is −$424.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.5M across reported positions. 15 SEC filings were submitted jointly with Matt Cohler.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
AMPL price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
MENLO PARK, CA 94025
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ESTC | Director | 15,912 | $101.17 | $1.61M | -$17.5K | 9 | 2026-10-19 |
| Confluent, Inc. (CFLT) Delisted | 10%+ Owner | 150,771 | $30.99 | $4.67M | -$8.73M | 3 | 2022-08-12 |
| AMPL | Director | 52,051 | $17.60 | $916.1K | -$416.16M | 2 | 2022-08-12 |
| AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | 10%+ Owner | 1,759,659 | $15.00 | $26.39M | $404.1K | 1 | 2018-06-28 |
Recent Filings
16 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-10-19 | ESTC | Grant (A) | +2,519 | $0 | EDGAR |
| 2025-10-02 | ESTC | Grant (A) | +2,663 | $0 | EDGAR |
| 2024-10-02 | ESTC | Grant (A) | +2,666 | $0 | EDGAR |
| 2023-12-13 | ESTC | Sell (S) | −5,000 | -$575.6K | EDGAR |
| 2023-12-11 | ESTC | Notice (144) | −5,000 | -$575.6K | EDGAR |
| 2023-10-10 | ESTC | Grant (A) | +2,627 | $0 | EDGAR |
| 2022-10-11 | ESTC | Grant (A) | +2,627 | $0 | EDGAR |
| 2022-08-12 | Confluent, Inc. (CFLT) Delisted | Sell (S) | −31,926 | -$1.03M | EDGAR |
| 2022-08-12 | AMPL | Sell (S) | −9,538 | -$171.8K | EDGAR |
| 2022-08-10 | Confluent, Inc. (CFLT) Delisted | Mixed | +1,564,542 | -$5.30M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.